iNtRON Biotechnology Inc (048530) — Cash Flow Reinvestment Rate
iNtRON Biotechnology Inc (048530) has a Cash Flow Reinvestment Rate of 0.88x as of March 2025, reinvesting ₩1.70 Billion (capex ₩321.62 Million plus investments ₩1.38 Billion) from operating cash flow of ₩1.94 Billion. See iNtRON Biotechnology Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
iNtRON Biotechnology Inc Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for iNtRON Biotechnology Inc across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of iNtRON Biotechnology Inc.
Annual Cash Flow Reinvestment Rate for iNtRON Biotechnology Inc (2015–2023)
Year-by-year capital reinvestment analysis for iNtRON Biotechnology Inc. See financial flexibility index of iNtRON Biotechnology Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 19.79x | ₩61.70 Billion | ₩3.12 Billion | ₩9.55 Billion | ▲ +157.7% |
| 2022 | 7.68x | ₩45.90 Billion | ₩5.98 Billion | ₩2.23 Billion | ▲ +207.6% |
| 2021 | 2.50x | ₩41.13 Billion | ₩16.47 Billion | ₩3.05 Billion | ▲ +38.5% |
| 2020 | 1.80x | ₩12.86 Billion | ₩7.13 Billion | ₩4.85 Billion | ▲ +634.2% |
| 2018 | 0.25x | ₩1.03 Billion | ₩4.20 Billion | ₩550.58 Million | ▼ -95.3% |
| 2015 | 5.19x | ₩8.83 Billion | ₩1.70 Billion | ₩6.30 Billion | — |